A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Completed · Phase 3 · Has a placebo group
Conditions studied: Glioblastoma
In brief
This study will be conducted as a randomized, double-blind, placebo-controlled, multi-center Phase 3 study. Approximately 300 subjects with newly diagnosed glioblastoma who meet all eligibility criteria will be enrolled.
Key facts
- Study ID
- NCT03776071
- Run by
- Denovo Biopharma LLC
- People needed
- 260
- Starts
- 2020-12-16
- Expected to finish
- 2024-02-29
- Last updated by the study team
- 2024-04-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Barrow Neurological Institute — Phoenix, Arizona, United States
- Mayo Clinic - Arizona — Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center - Duarte — Duarte, California, United States
- University of California San Diego Moores Cancer Center — La Jolla, California, United States
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- University of California Irvine Health Chao Family Comprehensive Cancer Center — Orange, California, United States
- The University of Southern California — Pasadena, California, United States
- University of California San Francisco Helen Diller Family Comprehensive CA Ctr — San Francisco, California, United States
- University of Colorado Hospital Anschutz Cancer Pavilion — Aurora, Colorado, United States
- Blue Sky Neurology — Englewood, Colorado, United States
- Smilow Cancer Hospital - New Haven — New Haven, Connecticut, United States
- Lynn Cancer Institute — Boca Raton, Florida, United States
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
- Sylvester Comprehensive Cancer Center — Miami, Florida, United States
- Miami Cancer Institute — Miami, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Rush University Medical Center — Chicago, Illinois, United States
- University of Kentucky Markey Cancer Center — Lexington, Kentucky, United States
- Norton Cancer Institute - Multidisciplinary Clinic — Louisville, Kentucky, United States
- University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States
- Henry Ford Health System — Detroit, Michigan, United States
- John Nasseff Neuroscience Institute — Minneapolis, Minnesota, United States
- Masonic Cancer Center — Minneapolis, Minnesota, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.